Home>Topics>Stocks>Mid-America Apartment Communities

Mid-America Apartment Communities MAA

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. REIT Valuation Part 3: Residential

      Headlines

      Thu, 28 Aug 2014

      By Dane Bowler : In this series of articles, we take a dive into REIT valuations across the various sectors to determine where there is still opportunity for outperformance. Part 1 covered healthcare , part 2 covered industrials and the focus of this article will be on residential REITs. ...

    2. Apartment REIT coverage launched at Mizuho

      Headlines

      Mon, 25 Aug 2014

      Started with Buys are Mid - America Apartment Communities ( MAA -0.1% ), and Camden Property Trust ( CPT ), and initiated at Neutral are Home Properties ( HME -0.4% ), and UDR ( UDR ). Post your comment!

    3. EMA accepts Cubist Pharma antibiotic MAA

      Headlines

      Fri, 22 Aug 2014

      The European Medicines Agency accepts Cubist Pharmaceuticals' (NASDAQ: CBST ) Marketing Authorization Application for ceftolozane/tazobactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections. The European Commission should announce its decision by

    4. UBS hedge fund rings the register on REITs

      Headlines

      Wed, 20 Aug 2014

      more than $900M after racking up big gains in the stocks this year. The biggest reductions were in Mid - America Apartment Communities ( MAA +0.3% ), AvalonBay ( AVB +0.8% ), and Equity Lifestyle Properties ( ELS +0.2% ), and

    5. Housing starts jump all about multifamily

      Headlines

      Wed, 20 Aug 2014

      Residential (NYSE: EQR ) and AvalonBay (NYSE: AVB ) are at all-time highs, but their owners may want to mull the fast pace of building. Others of interest: ESS , PPS , UDR , AIV , CPT , HME , MAA , TSRE , AEC , IRET , APTS Post your comment!

    6. Insmed to file MAA for Arikayce by year end

      Headlines

      Mon, 4 Aug 2014

      Following discussions with European regulatory authorities, Insmed Corp. (NASDAQ: INSM ) plans to file a Marketing Authorization Application with the EMA for Arikayce (liposomal amikacin for inhalation) for the treatment of nontuberculous mycobacteria (NTM) lung infections in treatment refractory

    7. Mid-America Apartment Communities' ( MAA ) CEO Eric Bolton on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Sat, 2 Aug 2014

      Mid - America Apartment Communities , Inc. (NYSE: MAA ) Q2 2014 Earnings Conference Call July 31, 2014 10:00 AM ET Executives Tim Argo ..... ladies and gentlemen. And thank you for participating in the MAA Second Quarter 2014 Earnings Conference Call. At this time

    8. Mid America Apartment misses by $0.07, misses on revenue

      Headlines

      Wed, 30 Jul 2014

      Mid America Apartment (NYSE: MAA ): Q2 FFO of $1.18 misses by $0.07 . Revenue of $244.49M (+85.5% Y/Y) misses by $2.3M . Press Release Post your comment!

    9. Orexigen receives 180 LOI from EMA regarding NB32 submission

      Headlines

      Wed, 30 Jul 2014

      180 List of Outstanding Issues to Orexigen Therapeutics ( OREX -2.7% ) regarding its Marketing Authorization Application ( MAA ) for NB32 (naltrexone/bupropion), its investigational drug candidate for weight loss. Orexigen believes it addressed the

    10. Durata sub out-licenses dalbavancin

      Headlines

      Wed, 30 Jul 2014

      of $15M and another payment of $10M upon EMA approval. It will also be eligible for milestone payments and royalties on sales. The MAA for dalbavancin is currently under EMA review. A decision is expected in 1H 2015. Post your comment!

    « Prev123Next »
    Content Partners